Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(16):1202-1203; doi:10.1093/jnci/96.16.1202
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Schultz, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schultz, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

Few Alternatives As HRT `Fountain of Youth' Runs Dry

James Schultz

The first 10% of the full text of this article appears below.

Once touted as the preferred means of banishing the worst ravages of menopause, hormone therapy—often referred to as hormone replacement therapy (HRT)—has fallen on hard times. Within the past 2 years, several major studies have revealed that, outside of reducing menopausal symptoms, HRT conveys more risk than benefit in terms of disease prevention.

The latest setback came in late June, with the publication of results from the Women's Health Initiative (WHI) Memory Study in the Journal of the American Medical Association. According to the study, the routine use of estrogen-alone HRT . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?